Alarm indicator for drug delivery devices
The drug delivery device with a retractable needle and alarm indicator addresses the challenge of prolonged infusion and confirms drug delivery completion through an audible alert, improving user interaction and infusion efficacy.
Patent Information
- Application Number
- JP2024525808
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-01
- Filing Date
- 2022-11-01
- Publication Date
- 2024-11-01
AI Technical Summary
Existing drug delivery devices face challenges in maintaining contact between the device and the target site for prolonged infusion times, especially when administering large volumes of liquid therapeutic formulations, and there is a need for user-friendly indicators to confirm drug delivery completion.
A drug delivery device with a retractable needle mechanism and an integrated alarm indicator that provides an audible alert when the needle is returned to a stored position after use, ensuring the delivery is complete.
The device ensures proper needle retraction and provides a clear audible signal to the user, confirming drug delivery completion, enhancing user experience and ensuring effective infusion without leakage.
Smart Images

Figure 2024540724000001_ABST
Abstract
Description
[Technical field]
[0001] This application claims priority to U.S. Provisional Application No. 63 / 274,284, filed November 1, 2021, which is incorporated by reference herein in its entirety. [Background technology]
[0002] The present disclosure relates to alarm indicators for drug delivery devices.
[0003] Various types of automatic injection or drug delivery devices have been developed to allow medications and other liquid therapeutic formulations to be administered or self-injected by untrained personnel. Generally, these devices include a reservoir pre-filled with the liquid therapeutic formulation and some type of automatic needle injection mechanism that can be triggered by the user. When the amount of fluid or drug to be administered is equal to or less than a certain amount, typically 1 mL, an automatic injector is generally used, and the injection time is usually about 10-15 seconds. When the amount of fluid or drug to be administered exceeds 1 mL, the injection time is generally longer, which results in the patient having difficulty maintaining contact between the device and the target site on the patient's skin. Furthermore, the larger the amount of drug to be administered, the longer the injection time is desired. The traditional method of slowly injecting a drug into a patient is to start an infusion and slowly inject the drug into the patient's body. Such procedures are usually performed in a hospital or outpatient setting.
[0004] Certain devices allow for self-injection in a home environment, slowly infusing the liquid therapeutic formulation into the patient's skin. In some cases, these devices are small enough (both in height and overall size) to be "worn" by the patient while the liquid therapeutic formulation is being injected into the patient. These devices typically include a pump or other type of delivery mechanism to force the liquid therapeutic formulation out of a reservoir and into an injection needle. Such devices also typically include a valve or flow control mechanism to initiate the flow of the liquid therapeutic formulation at the appropriate time, and a trigger mechanism to initiate the injection. Summary of the Invention
[0005] In one aspect or embodiment, the drug delivery device includes a housing, a needle having a retracted position and an extended position, a needle actuator body received within the housing and configured to move from a pre-use position in which the needle is in the retracted position to a use position in which the needle is in the extended position and a post-use position in which the needle is in the retracted position, a container received within the housing and configured to hold a dose of a medicament, a drive assembly configured to move the dose of the medicament from the container to the needle, and an alarm indicator received within the housing, wherein the needle actuator body activates the alarm indicator when the needle actuator body is in the post-use position.
[0006] The alarm indicator may be an audible indicator. The alarm indicator may include an actuator member, with the needle actuator body engaging the actuator member when the needle actuator body moves from the use position to the post-use position. The alarm indicator may include a metal arm body and a helical spring, with the helical spring configured to engage with the metal arm body when the alarm indicator is activated. The needle actuator body may include cross ribs, with the cross ribs engaging the actuator member when the needle actuator body moves from the use position to the post-use position.
[0007] The container may include a body, a closure, and a stopper movable within the body, the drive assembly being configured to engage the stopper.
[0008] The device may further include an actuator button movable from a first position to a second position relative to the housing to actuate the needle actuator body from a pre-use position to a use position. The actuator button may be configured to actuate the drive assembly. The alarm indicator may be electromechanical.
[0009] The needle may extend at least partially from the housing when the needle is in the extended position and the needle may be fully disposed within the housing when the needle is in the retracted position. The drive assembly may include at least one spring. [Brief description of the drawings]
[0010] The above and other features and advantages of the present disclosure, as well as the manner in which they are accomplished, will become more apparent, and the disclosure itself will be better understood, by reference to the following description of embodiments of the disclosure taken in conjunction with the accompanying drawings. [Figure 1] FIG. 1 is a perspective view of a drug delivery device according to one aspect or embodiment of the present application. [Diagram 2] 2 is a perspective cross-sectional view of the drug delivery device of FIG. 1. [Diagram 3] 3 is a front cross-sectional view of the drug delivery device of FIG. 1. FIG. [Figure 4] FIG. 4 is a top view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in a pre-use position. [Diagram 5] FIG. 5 is a top cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a pre-use position. [Figure 6] FIG. 6 is a front cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a pre-use position. [Figure 7] FIG. 7 is a top view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in an initial operating position. [Figure 8] FIG. 8 is a top cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in an initial actuated position. [Figure 9] FIG. 9 is a front cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in an initial actuated position. [Figure 10] FIG. 10 is a top view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in the position of use. [Figure 11]FIG. 11 is a top cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a position for use. [Figure 12] FIG. 12 is a front cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a position of use. [Figure 13] FIG. 13 is a top view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in a post-use position. [Figure 14] FIG. 14 is a top cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a post-use position. [Figure 15A] FIG. 15A is a front cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a post-use position. [Figure 15B] FIG. 15B is a front cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a pre-use position. [Figure 15C] FIG. 15C is a perspective cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a pre-use position. [Figure 16] FIG. 16 is a top view of the drug delivery device of FIG. 1 showing the drug delivery device in a post-use position with the top of the housing removed and the alarm indicator activated. [Figure 17] FIG. 17 is a perspective view of an alarm indicator according to one aspect or embodiment of the present application. [Figure 18] FIG. 18 is a perspective view of a needle actuator body according to one aspect or embodiment of the present application.
[0011] Corresponding reference characters indicate corresponding parts throughout the several views. The illustrations presented herein illustrate exemplary embodiments of the present disclosure, and such illustrations are not to be construed as limiting the scope of the present disclosure in any way. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0012] The following description is provided to enable those skilled in the art to make and use the described embodiments intended to practice the invention. However, various modifications, equivalents, variations, and alternatives will be readily apparent to those skilled in the art. Any and all such modifications, variations, equivalents, and alternatives are intended to be within the spirit and scope of the present invention.
[0013] For purposes of description hereinafter, the terms "top", "bottom", "right", "left", "vertical", "horizontal", "top", "bottom", "transverse", "longitudinal" and their derivatives refer to the present invention as oriented in the drawings. However, it will be understood that the present invention may be subject to various alternative modifications unless expressly specified to the contrary. It should also be understood that the specific devices illustrated in the accompanying drawings and described in the following specification are merely exemplary embodiments of the present invention. As such, specific dimensions and other physical characteristics relating to the embodiments disclosed herein are not to be considered as limiting.
[0014] 1-18, the drug delivery device 10 includes a drive assembly 12, a reservoir 14, a valve assembly 16, and a needle actuator assembly 18. The drive assembly 12, the reservoir 14, the valve assembly 16, and the needle actuator body 18 are at least partially disposed within a housing 20. The housing 20 includes a top 22 and a bottom 24, although other suitable arrangements of the housing 20 may be utilized. In one embodiment, the drug delivery device 10 is an injector device configured to be worn or secured to a person and to deliver a predetermined dose of a medication provided within the reservoir 14 to the person by injection. The device 10 may be utilized for "bolus injection," which is administration of a medication within a set time period. The medication may be administered over a period of up to 45 minutes, although other suitable injection volumes and durations may be utilized. The bolus administration or delivery may be rate controlled or may not be rate controlled. The device 10 may deliver medication to a user at a constant pressure, and at a variable rate. The general operation of device 10 is described below in conjunction with FIGS.
[0015] 1-17, the device 10 is configured to be actuated by engagement of an actuation button 26 by a user, resulting in a needle 28 of the needle actuator assembly 18 penetrating the skin of the user, and actuation of the drive assembly 12 to place the needle 28 in fluid communication with the container 14, expel fluid or medicament from the container 14, and withdraw the needle 28 after infusion of the medicament is completed. The operation of the device 10 may be similar to that described in U.S. Patent Application Publication No. 2017 / 0354788, which is incorporated herein by reference in its entirety. The housing 20 of the device 10 includes an indicator window 30 for viewing an indicator arrangement 32 configured to provide an indication to the user regarding the status of the device 10, and a container window 31 for viewing the container 14. The indicator window 30 may be a magnifying lens for clearly viewing the indicator arrangement 32. The indicator arrangement 32 moves with the needle actuator assembly 18 during use of the device 10 to indicate a pre-use state, a use state, and a post-use state of the device 10. The indicator arrangement 32 provides a visual indication of the status.
[0016] 4-6, in the pre-use position of the device 10, the container 14 is spaced from the drive assembly 12 and the valve assembly 16, and the needle 28 is in an extended position. As shown in FIGS. 7-9, during initial actuation of the device 10, the drive assembly 12 is released after movement of the actuation button 26 to engage the container 14 and move the container 14 from a first position to a second position axially spaced from the first position while engaging the container 14 with the valve assembly 16. Movement of the container 14 towards the valve assembly 16 is configured to penetrate a closure 36 of the container 14 and place the medicament within the container 14 in fluid communication with the needle 28 via a tube 37 or other suitable arrangement. The drive assembly 12 is configured to engage a stopper 34 disposed within a body or barrel 35 of the container 14, and the incompressibility of the fluid or medicament within the container 14 initially moves the entire container 14 into engagement with the valve assembly 16. Initial actuation of device 10 is caused by engagement of actuator button 26 by a user, which releases needle actuator assembly 18 and drive assembly 12, as described in more detail below. During initial actuation, needle 28 is still in the retracted position and attempts to move to the extended position to provide an injection to a user of device 10.
[0017] As shown in Figures 10-12, in the use position of the device 10, the needle 28 is at least partially in an extended position outside the housing 20, and the drive assembly 12 moves a stopper 34 in the container 14 to deliver medicament from the container 14 through the needle 28 to a user. In the use position, the drive assembly 12 can also move the stopper 34 relative to the container 14, since the valve assembly 16 has already penetrated a closure 36 of the container 14 to place the container 14 in fluid communication with the needle 28, thereby allowing fluid to be dispensed from the container 14. In the post-use position of the device 10, shown in Figures 13-15A, the needle 28 is in a retracted position and engages the pad 38 to seal the needle 28 and prevent residual flow of fluid or medicament from the container 14.
[0018] 1-17, the needle actuator assembly 18 includes a needle actuator body 40 that is received within the housing 20 and configured to move from a pre-use position (FIGS. 3-6) in which the needle 28 is in a retracted position to a use position (FIGS. 10-12) in which the needle 28 is in an extended position. In the retracted position, the needle 28 is disposed entirely within the housing 20, and in the extended position, the needle 28 is disposed at least partially outside the housing 20. The needle actuator body 40 also has a post-use position (FIGS. 13-15A) in which the needle 28 is in the retracted position and engages the pad 38, as described above. The needle actuator body 40 is biased from the pre-use position to the post-use position by a spring 42. As described above, the operating button 26 is movable from a first position to a second position relative to the housing 20 to actuate the needle actuator body 40 from the pre-use position to the use position. In one aspect or embodiment, movement of the actuator button 26 from the first position to the second position moves the needle actuator body 40 out of engagement with the housing 20 or another component and allows the spring 42 to bias the needle actuator body 40 from a pre-use position to a use position and to a post-use position. The needle actuator body 40 moves the needle 28 between the retracted and extended positions via a cam mechanism as the needle actuator body 40 moves between the retracted and extended positions, although other suitable arrangements may be utilized.
[0019] 16 and 17, in one aspect or embodiment, the drug delivery device 10 includes an alarm indicator 70 received within the housing 20. The needle actuator body 40 activates the alarm indicator 70 when the needle actuator body 40 is in a post-use position. The alarm indicator 70 is an audible indicator. The alarm indicator 70 is configured to provide an audible indication to the patient that the drug delivery device 10 has completed delivery of a dose of the medication.
[0020] The alarm indicator 70 includes an actuator member 72 with which the needle actuator body 40 engages when the needle actuator body 40 moves from a use position to a post-use position. In one aspect or embodiment, as shown in FIG. 17, the alarm indicator 70 also has a metallic alarm body 74 and a helical spring 76 configured to engage with the metallic arm body 74 when the alarm indicator 70 is activated. More specifically, when the needle actuator body 40 engages with the actuator member 72, the helical spring 76 may be released and contact the metallic arm body 74 to provide an audible indication or ringing sound. In one aspect or embodiment, the ringing sound provided by the alarm indicator 70 lasts for at least 2 seconds, at least 5 seconds, or at least 10 seconds. The alarm indicator 70 also includes a support plate 78 that houses the actuator member 72, the metallic alarm body 74, and the helical spring 76. The support plate 78 may be secured to the housing 20 of the drug delivery device 10.
[0021] With reference to FIG. 18, in one aspect or embodiment, the needle actuator body includes cross ribs 80 that engage the actuator member 72 when the needle actuator body 40 moves from the use position to the post-use position.
[0022] In one aspect or embodiment, the alarm indicator 70 is electromechanical. The alarm indicator 70 may be an electric, battery-powered call bell. In a further aspect or embodiment, the alarm indicator 70 includes multiple gears. In another aspect or embodiment, the alarm indicator 70 may function similarly to a service call bell including a cantilever feature that strikes the metal alarm body 74.
[0023] Elements of one disclosed aspect can be combined with elements of one or more other disclosed aspects to form different combinations, all of which are contemplated within the scope of the invention.
[0024] While the present disclosure has been described as having an exemplary structure, the present disclosure can be further modified within the spirit and scope of the present disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the present disclosure using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which the disclosure pertains and fall within the scope of the appended claims.
Claims
1. Housing and a needle having a retracted position and an extended position; a needle actuator body received within the housing and configured to move from a pre-use position in which the needle is in the retracted position, to a use position in which the needle is in the extended position, and to a post-use position in which the needle is in the retracted position; a container received within the housing, the container configured to hold a dose of a medicament; a drive assembly configured to move a dose of medicament from the container to the needle; an alarm indicator received within the housing, the alarm indicator activating the alarm indicator when the needle actuator body is in the post-use position; and A drug delivery device comprising:
2. The drug delivery device of claim 1 , wherein the alarm indicator comprises an audible indicator.
3. The drug delivery device of claim 2 , wherein the alarm indicator includes an actuator member, the needle actuator body engaging with the actuator member when the needle actuator body moves from the use position to the post-use position.
4. 4. The drug delivery device of claim 3, wherein the alarm indicator includes a metallic arm body and a helical spring, the helical spring configured to engage with the metallic arm body when the alarm indicator is activated.
5. The drug delivery device of claim 3 , wherein the needle actuator body includes a cross rib that engages the actuator member when the needle actuator body moves from the use position to the post-use position.
6. The drug delivery device of claim 1 , wherein the container includes a body, a closure, and a stopper movable within the body, and the drive assembly is configured to engage the stopper.
7. The drug delivery device of claim 1 , further comprising an operating button movable from a first position to a second position relative to the housing to actuate the needle actuator body from the pre-use position to the use position.
8. The drug delivery device of claim 7 , wherein the operating button is configured to actuate the drive assembly.
9. The drug delivery device of claim 1 , wherein the alarm indicator is electromechanical.
10. 2. The drug delivery device of claim 1, wherein when the needle is in the extended position, the needle extends at least partially from the housing, and when the needle is in the retracted position, the needle is fully disposed within the housing.
11. The drug delivery device of claim 1 , wherein the drive assembly comprises at least one spring.
Citation Information
Patent Citations
Injection device
JP2007500561A
Retraction mechanism for small automatic injection device
JP2016517301A
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US20120217184A1
